REW 40 Index
Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Bristol-Myers Squibb Co. (NY: BMY)
46.85 USD  UNCHANGED
Official Closing Price  /  Updated: 6:40 PM EDT, Jun 18, 2013  /  Add to My Watchlist      
View: Quote News Research
All news about Bristol-Myers Squibb Co.
 
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Bristol-Myers (BMY), AstraZeneca (AZN) SAVOR-TIMI-53 Misses Primary Efficacy Endpoint in Phase 4
Today 6:20 EDT
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8429774 for the full story. Read More
from StreetInsider.com News Articles
UPDATE 1-AstraZeneca, Bristol diabetes drug disappoints in key test
Today 2:55 EDT
LONDON, June 19 (Reuters) - AstraZeneca and Bristol-Myers Squibb's diabetes drug Onglyza failed to reduce heart risks in a large clinical study, disappointing investors who had thought it might... Read More
category companyNews
from Reuters: Company News
AstraZeneca, Bristol diabetes drug fails to show heart benefit
Today 2:15 EDT
LONDON, June 19 (Reuters) - AstraZeneca and Bristol-Myers Squibb's diabetes drug Onglyza failed to reduce heart risks in a large clinical study. Read More
category companyNews
from Reuters: Company News
AstraZeneca and Bristol-Myers Squibb Announce Top Line Results for SAVOR-TIMI-53 Cardiovascular Outcomes Trial of Onglyza® (saxagliptin)
Today 2:02 EDT
from Business Wire News Releases
Medtronic Saga: Corrupt Science, Belated Warning
June 18, 2013
category AZN , ABBV , MDT , and 4 more.
from YCharts
BIO-TECH STOCKS: AcelRx Pharmaceuticals Inc, Bristol Myers Squibb Co., ImmunoCellular Therapeutics Ltd, Infinity Pharmaceuticals Inc.
June 18, 2013
Huntington Beach, CA -- (SBWIRE) -- 06/18/2013 -- PSPicks.com provides its subscribers with a free newsletter that reports up to the minute information and exclusive charts on cheap, undervalued,... Read More
from SBWire - Latest Press Releases
Supreme Court Permits Antitrust Scrutiny Of Pharma Settlements
June 18, 2013
In a ruling that is likely to have a far-reaching impact on the pharmaceutical industry, the Supreme Court permitted antitrust scrutiny of reverse pay settlements used between brand name drug makers... Read More
category NYSE:MRK , NYSE:PFE , NYSE:BMY , and 1 more.
from Forbes Real Time
Bristol-Myers Squibb Grants Help K-12 Educators Bring Science to Life and Help Students Explore Their Interests in the Sciences and Science-Based Careers
June 18, 2013
from Business Wire News Releases
Insider Trading Investment for Bank of America, Hewlett-Packard, Bristol Myers Squibb, Annaly Capital Management, Walt Disney, and American Capital Agency
June 18, 2013
from PR Newswire
Key to Success, How to Profit: FSLR, NWSA, BMY and LULU
June 18, 2013
from Marketwired News Releases
Pharma Stocks: Court Ruling's Real Meaning
June 17, 2013
category AZN , SNY , MRK , and 4 more.
from YCharts
Supreme Court Ruling Creates Uncertainly for Drug Makers (ACT) (MYL) (MRK)
June 17, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8422776 for the full story. Read More
from StreetInsider.com News Articles
USMV, BMY, PEP, CB: ETF Outflow Alert
June 17, 2013
Symbols mentioned in this story: USMV, BMY, PEP, CB Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These ''units''... Read More
category ETFs
from ETF Channel
Cramer: A 'Nightmare Scenario' for Bulls and Bears
June 17, 2013
Jim Cramer has become more cautious on the market right now and conditions are creating a "nightmare scenario" for just about everyone involved, he said on CNBC. Read More
category General Mills Inc , Squawk on the Street , tv6in60 , and 2 more.
from CNBC.com News
BCG Weighs In On First-In-Class Vs. Best-In-Class Drugs -- How Valuable Is Their Advice?
June 17, 2013
The hardest decisions facing a head of a pharmaceutical R&D organization involve determining which great ideas to fund. One might think this is a simple process, that any idea which can lead to a new... Read More
category NYSE:PFE , NYSE:BMY
from Forbes Real Time
Litigation Settlements, Data Compliance Reviews, and Clinical Trials Pave Way for Solid Footing in Healthcare - Research Report on Pfizer, Merck, Bristol-Myers Squibb, Keryx and Pacira Pharmaceuticals
June 17, 2013
Editor Note: For more information about this release, please scroll to bottom Read More
from PR Newswire
UK scientists win funding for new kind of anticoagulant drug
June 16, 2013
LONDON, June 17 (Reuters) - British scientists have won early financial backing for a new kind of anticoagulant drug they believe may prevent dangerous blood clots without causing bleeding - a... Read More
category companyNews
from Reuters: Company News
Bristol-Myers Squibb, AbbVie Announce Progression-Free Survival Data from Phase 2 Multiple Myeloma Study
June 15, 2013
Bristol-Myers Squibb Company (NYSE: BMY ) and AbbVie (NYSE: ABBV ) today announced updated efficacy and safety data from a small, randomized Phase 2, open-label study in patients with... Read More
category Contracts , ABBV , Management , and 5 more.
from Latest Articles from Benzinga.com
Bristol-Myers Squibb and AbbVie Announce Progression-Free Survival Data from Phase 2 Open-Label Study of Investigational Agent Elotuzumab in Combination with Lenalidimide and Dexamethasone in Previous
June 15, 2013
from Business Wire News Releases
Week in Review: Mindray Medical Buys US Ultrasound Company for $105 Million
June 15, 2013
Mindray Medical will pay $105 million to acquire Zonare Medical Systems, a California high-end ultrasound device maker; Simcere Pharma announced a third drug development collaboration with... Read More
from ChinaBio® Today
4 Pharmaceutical Stocks to Buy Now
June 14, 2013
 Read More
category NYSE:JNJ , NYSE:WPI , Stocks to Buy , and 2 more.
from InvestorPlace - Latest Headlines
AstraZeneca and Bristol-Myers Squibb to Present New Data at American Diabetes Association 73rd Scientific Sessions®
June 14, 2013
from Business Wire News Releases
Bristol-Myers Squibb and Simcere Enter Partnership to Co-Develop and Co-Commercialize Orencia(R) SC (abatacept) in China
June 14, 2013
from PR Newswire
Bristol-Myers Squibb and Simcere Enter Partnership to Co-Develop and Co-Commercialize Orencia® SC (abatacept) in China
June 14, 2013
from Business Wire News Releases
Simcere Announces Third Drug Development Partnership with BMS
June 14, 2013
Simcere Pharma has formed a third drug development collaboration with Bristol-Myers Squibb. For the first time, the project involves a biologic molecule: a subcutaneous formulation of Orencia®, a... Read More
from ChinaBio® Today
It’s Time to ‘Put’ Your Big Winners in Protection Mode
June 14, 2013
 Read More
category NASDAQ:MU , NASDAQ:APOL , NASDAQ:MNST , and 3 more.
from InvestorPlace - Latest Headlines
Knucklehead Buybacks; How to Find Smart Ones
June 13, 2013
category PRU , MA , WMT , and 7 more.
from YCharts
Perfect Trade Setups, How to Play ARNA, BMY, MO and GT
June 13, 2013
from Marketwired News Releases
Cramer: How to Ride Out the Weakness
June 12, 2013
"I'm not crazy about the market," Cramer said. "We have taken my charitable trust's cash position to a much higher level than usual," revealed the Mad Money host on Wednesday's broadcast. Read More
category Investing , Investing/Market Outlook , General Mills Inc , and 11 more.
from CNBC.com News
Drugmakers to cooperate in safety review of diabetes drugs
June 12, 2013
NEW YORK, June 12 (Reuters) - Global drugmakers said on Wednesday they would cooperate with an independent review to address concerns of a potential link between widely used diabetes medicines and... Read More
category companyNews
from Reuters: Company News
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here